🇺🇸 FDA
Pipeline program

JANX014

PRCA-014-001

Phase 1 mab active

Quick answer

JANX014 for Prostate Cancer is a Phase 1 program (mab) at Janux Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Janux Therapeutics
Indication
Prostate Cancer
Phase
Phase 1
Modality
mab
Status
active

Clinical trials